Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/S ratio is N/A as of 2026-10-06T19:45:48.387Z.
Calculation as of: 2026-10-06T19:45:48.387Z.
Quote observation: 2026-10-06T19:45:13.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 9a6fb48ec682e3cf9a2a3de0b7f1962f0667ac92b413acd908fc1cfb112ec24a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
N/A
Market Cap
$48.99M
PS Ratio
141.58
TTM Avg
825.85
3Y Avg
825.85
5Y Avg
825.85
Market Cap
$49.42M
PS Ratio
1.57
TTM Avg
1.42
3Y Avg
1.62
5Y Avg
1.97
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Apollomics, Inc. (APLM) | $48.73M | N/A | N/A | N/A | N/A |
| INmune Bio, Inc. (INMB)vs › | $48.78M | N/A | 1293.91 | 1758.59 | 3330.34 |
| Microbot Medical Inc. (MBOT)vs › | $48.99M | 141.58 | 825.85 | 825.85 | 825.85 |
| TELA Bio, Inc. (TELA)vs › | $48.99M | 0.61 | 0.61 | 1.28 | 2.70 |
| Sensus Healthcare, Inc. (SRTS)vs › | $48.23M | 2.76 | 2.20 | 2.26 | 2.94 |
| Precision Optics Corporation, Inc. (POCI)vs › | $49.42M | 1.57 | 1.42 | 1.62 | 1.97 |
| Lite Strategy, Inc. (LITS)vs › | $47.47M | N/A | N/A | N/A | N/A |
| Instil Bio, Inc. (TIL)vs › | $47.41M | N/A | 32485.46 | 32485.46 | 32485.46 |
| Clene Inc. (CLNN)vs › | $50.31M | 255.37 | 342.08 | 169.55 | 218.69 |
| Tenax Therapeutics, Inc. (TENX)vs › | $50.53M | N/A | 1214.61 | 1444.04 | 930.10 |
Half-year reporter: no trailing two-half-year basis, because the newest half-year ended more than 270 days before this quote.
The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
P/S Ratio
N/A
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
